Stocks Health care STIM
NASDAQ · Health careNeuronetics, Inc. (STIM)
Neuronetics, Inc. brought in $159.8M of revenue over the twelve months to September 30, 2026, up 23.0% from a year earlier. It posted a net loss of $23.1M. In fiscal 2025 capital spending exceeded operating cash flow by $21.2M. At September 30, 2026 it held $22.1M in cash against $61.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Neuronetics, Inc.
- Net worth
- Neuronetics, Inc. has a market value (market cap) of $166.1M at the latest share price, and shareholders' equity of $18.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $149.2M (+99.2% year on year), with a net loss of $39M. Over the 12 months to September 30, 2026: revenue $159.8M, net loss $23.1M.
- Cash flow
- In fiscal 2025 operations used $20.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Neuronetics, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Neuronetics, Inc. does
Neuronetics, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker STIM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $149.2M | -$39M | -$0.59 | -$21.2M |
| 2024 | $74.9M | -$43.7M | -$1.38 | -$32.5M |
| 2023 | $71.3M | -$30.2M | -$1.05 | -$34.4M |
| 2022 | $65.2M | -$37.2M | -$1.38 | -$34M |
| 2021 | $55.3M | -$31.2M | -$1.22 | -$30.3M |
| 2020 | $49.2M | -$27.5M | -$1.46 | -$29.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where STIM ranks in Health care
Latest SEC filings
What Neuronetics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 13% to $42M versus the same quarter last year; diluted EPS -$0.02 versus -$0.13.
- November 4, 2026
- August 24, 2026Activist stake changed SCHEDULE 13D/A
- August 17, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 11, 2026
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.1% to $41.6M versus the same quarter last year; diluted EPS -$0.05 versus -$0.15.
- August 11, 2026
- August 4, 2026Activist stake changed SCHEDULE 13D/A
- July 20, 2026
Insider trades
What the people running Neuronetics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $85.1K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 30, 2026 | Chernett Jorey10% owner | Bought | 18,000 | $40.9K |
| August 14, 2026 | Chernett Jorey10% owner | Bought | 14,000 | $44.2K |
| July 23, 2026 | Naor NirEVP, CFO & Treasurer | Received as pay | 500,000 | - |
| July 14, 2026 | Chernett Jorey10% owner | Bought | 35,000 | $62.3K |
| June 15, 2026 | Madryn Asset Management, LP10% owner | Other changeindirect | 2,934 | - |
| June 15, 2026 | Madryn Asset Management, LP10% owner | Other changeindirect | 34,932 | - |
| June 15, 2026 | Madryn Asset Management, LP10% owner | Other changeindirect | 4,634 | - |
| June 15, 2026 | Amin AvinashDirector | Other change | 2,934 | - |
Who owns STIM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Madryn Asset Management, LP13D, may seek influence with 7 related filers | 30.3% | March 4, 2026 |
| Chernett Jorey13D, may seek influence | 13.92% | August 24, 2026 |
| Parian Ultreia LP13G, passive | 7% | March 17, 2026 |
| Point72 Asset Management, L.P.13G, passive with 2 related filers | 5% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 87 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Madryn Asset Management, LP | 18,540,488 | +64,595 |
| UBS Group AG | 2,279,099 | -591,499 |
| Wexford Capital LP | 2,002,625 | +1,301,664 |
| FourWorld Capital Management LLC | 1,744,142 | +254,820 |
| Lane Generational LLC | 1,633,372 | -141,252 |
| Vanguard Capital Management LLC | 1,507,097 | -540,878 |
| Masters Capital Management LLC | 1,000,000 | 0 |
| AdvisorShares Investments LLC | 742,795 | +125,602 |
| Ikarian Capital, LLC | 701,182 | 0 |
| BlackRock, Inc. | 596,622 | -1,721,915 |
| HighTower Advisors, LLC | 563,741 | +1,371 |
| Marshall Wace, Llp | 485,692 | new |
| Geode Capital Management, LLC | 458,474 | -500,515 |
| Citadel Advisors LLC | 421,903 | +345,306 |
| Dauntless Investment Group, LLC | 369,187 | +99,979 |
| State Street Corp | 290,299 | -552,248 |
| Centiva Capital, LP | 285,913 | +116,594 |
| Vanguard Fiduciary Trust Co | 264,734 | +6,700 |
| Goldman Sachs Group Inc | 264,088 | +30,498 |
| JBF Capital, Inc. | 233,166 | 0 |
Insiders
13 insiders reported holding 21,237,135 shares in total, about $46.3M at the last price.
| Holder | Shares |
|---|---|
| Chernett Jorey10% owner | 10,620,988 |
| Madryn Asset Management, LP10% owner | 2,269,0732,269,073 held indirectly |
| Sullivan Keith JFormer Officer & Director | 1,590,924 |
| Cucuz SashaDirector | 1,542,798 |
| Reuvers Daniel L.President and CEO | 1,500,000 |
| Macan William AndrewEVP, CLO and CS | 897,270 |
| Pfanstiel StevenFormer EVP, CFO and Treasurer | 836,643 |
| Cascella RobertDirector | 625,017 |
| Naor NirEVP, CFO & Treasurer | 500,000 |
| Muir Glenn PDirector | 401,816 |
Questions about STIM
What does Neuronetics, Inc. do?
Neuronetics, Inc. is a company in the Health care sector, listed on NASDAQ as STIM. Its shares trade on NASDAQ under the ticker STIM.
What is Neuronetics, Inc.'s net worth?
Neuronetics, Inc. has a market value (market cap) of $166.1M at the latest share price, and shareholders' equity of $18.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Neuronetics, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $23.1M on revenue of $159.8M.
How much revenue does Neuronetics, Inc. make?
Over the twelve months to September 30, 2026 Neuronetics, Inc. reported revenue of $159.8M. That is 23.0% more than a year earlier.
When did Neuronetics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026.
When is Neuronetics, Inc.'s next earnings report?
Neuronetics, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare STIM with
Follow STIM
Get an email when Neuronetics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Neuronetics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.